BiotechTube
Home/Novadiol/Tom Krol
TK

Tom Krol

Chief Development Officer

Novadiol

Therapeutic Areas

NephrologyChronic Kidney Disease

Novadiol Pipeline

DrugIndicationPhase
Dendocrin™Secondary Hyperparathyroidism (SHPT) in Stage 3 & 4 Chronic Kidney Disease (CKD) with Vitamin D DeficiencyPhase 3

Leadership Team at Novadiol

GG
GP Georges
Chief Executive Officer
View full Novadiol profile